Pharmacotherapy for Attention-Deficit/Hyperactivity Disorder and Retention in Outpatient Substance Use Disorder Treatment: A Retrospective Cohort Study

Pharmacotherapy for Attention-Deficit/Hyperactivity Disorder and Retention in Outpatient Substance Use Disorder Treatment: A Retrospective Cohort Study organized by CME Institute of Physicians Postgraduate Press, Inc. (PPP)

Activity opens: 03/03/2021
Activity expires: 04/30/2023

Description:
How does comorbid attention-deficit/hyperactivity disorder (ADHD) affect individuals with substance use disorder (SUD)? Is treatment for ADHD associated with retention in outpatient SUD therapy?

Learning Objectives:
After studying this article, you should be able to:
•  Refer to available evidence when weighing the risks and benefits of providing medication treatment for attention-deficit/hyperactivity disorder during outpatient treatment for substance use disorder

Additional details will be posted as soon as information is available.